Old Web
English
Sign In
Acemap
>
Paper
>
P2.15-26 Rates and Economic Burden of Adverse Events in Patients With Metastatic NSCLC Treated with EGFR-TKIs
P2.15-26 Rates and Economic Burden of Adverse Events in Patients With Metastatic NSCLC Treated with EGFR-TKIs
2018
J. Subramanian
François Laliberté
Ancilla Fernandes
M. Pavilack
Philippe Jacques
Mei Sheng Duh
Keywords:
General surgery
Cancer research
Adverse effect
Medicine
in patient
Oncology
egfr tkis
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]